Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 21

Trial Status

Completed1
Recruiting1
Terminated1
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT04729725Phase 1Terminated
SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
PrincipalinvestigatorStart date: 2021-02-09
NCT04693468Phase 1Recruiting
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm
PrincipalinvestigatorStart date: 2020-12-01
NCT04266912Phase 1/2Active Not Recruiting
Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors
Metastatic Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
PrincipalinvestigatorStart date: 2020-03-17
NCT03291938Phase 1Completed
IACS-010759 in Advanced Cancers
Advanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+22 more
PrincipalinvestigatorStart date: 2017-11-13

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Stage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8Stage II Pancreatic Cancer AJCC v8+9 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

A P Chen

National Cancer Institute LAO

Related
8 trials

Shared therapeutic areas:

Metastatic Malignant Solid NeoplasmAdvanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8+6 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Lorenzo Cohen

M.D. Anderson Cancer Center

Related
10 trials

Shared therapeutic areas:

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+5 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score9%

Flemming Forsberg, phD

Thomas Jefferson University

Related
9 trials

Shared therapeutic areas:

Stage II Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer AJCC v8Stage IIB Pancreatic Cancer AJCC v8+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Shannon N Westin

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Estrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+1 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score4%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm+1 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score4%

David Hui, MD

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score3%

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score3%

Pamela Munster, MD

University of California, San Francisco

Related
8 trials

Shared therapeutic areas:

Anatomic Stage IV Breast Cancer AJCC v8Metastatic Malignant Solid NeoplasmPrognostic Stage IV Breast Cancer AJCC v8
Similarity Score3%

Joanne Mortimer

City of Hope Medical Center

Related
8 trials

Shared therapeutic areas:

Anatomic Stage IV Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Prognostic Stage IV Breast Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT04729725Phase 1PrincipalInvestigator

SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
Terminated
NCT04693468Phase 1PrincipalInvestigator

Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm
Recruiting
NCT04266912Phase 1/2PrincipalInvestigator

Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors

Metastatic Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
Active Not Recruiting
NCT03291938Phase 1PrincipalInvestigator

IACS-010759 in Advanced Cancers

Advanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+22 more
Completed

All 4 trials loaded